Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases by Jessica | Sep 2, 2025 Read more »
AeroRx Therapeutics Announces Topline Positive Phase 2a Data for Inhaled AERO-007, the First Nebulized LABA/LAMA Combination in Development for COPD by Jessica | Jul 30, 2025 Read more »
Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease by Jessica | Jun 17, 2025 Read more »
Casma Therapeutics Nominates CSM-101 as a Development Candidate for the Treatment of Rare and Common Forms of Parkinson’s Disease by Jessica | Jun 5, 2025 Read more »
TRexBio Doses First Participant in Phase 1 Trial of TRB-061, a Novel TNFR2 Agonist for Atopic Dermatitis and Other Inflammatory Diseases by Jessica | Jun 3, 2025 Read more »
